Avadel Pharmaceuticals (AVDL) Current Leases: 2010-2021
Historic Current Leases for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Dec 2021 value amounting to $900,000.
- Avadel Pharmaceuticals' Current Leases rose 100.60% to $1.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.0 million, marking a year-over-year increase of 100.60%. This contributed to the annual value of $900,000 for FY2021, which is 89.87% up from last year.
- Avadel Pharmaceuticals' Current Leases amounted to $900,000 in FY2021, which was up 89.87% from $474,000 recorded in FY2020.
- In the past 5 years, Avadel Pharmaceuticals' Current Leases ranged from a high of $900,000 in FY2021 and a low of $474,000 during FY2020.
- For the 3-year period, Avadel Pharmaceuticals' Current Leases averaged around $673,000, with its median value being $645,000 (2019).
- As far as peak fluctuations go, Avadel Pharmaceuticals' Current Leases decreased by 26.51% in 2020, and later surged by 89.87% in 2021.
- Over the past 3 years, Avadel Pharmaceuticals' Current Leases (Yearly) stood at $645,000 in 2019, then decreased by 26.51% to $474,000 in 2020, then soared by 89.87% to $900,000 in 2021.